The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that its campaign is “truthful.”
An article from
Dive Brief
//
Obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines.
Novo Nordisk sues Eli Lilly over "maliciously and deceptively false" GLP-1 ads
Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads
Novo sues Lilly over 'deceptive' ads comparing GLP-1 drug doses
Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drug
Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising
GLP-1 Fight: Novo Sues Eli Lilly Over Nationwide "Deceptive Advertising" Campaign
Novo Nordisk files lawsuit accusing rival Eli Lilly of running ‘false and misleading’ GLP-1 ads
Novo Nordisk suing Eli Lilly over GLP-1 ‘outdated’ advertisements - UPI.com
Wegovy maker sues rival Eli Lilly over 'deliberately false' GLP-1 ads
Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising - Novo Nordisk (NYSE:NVO)
The lawsuit alleges that Eli Lilly misled consumers by using outdated clinical trial data to make its drugs appear more effective…
The weight-loss drug wars reached a new level of intensity Tuesday as Novo Nordisk sued Eli Lilly, accusing its arch-rival of…
Novo Nordisk sues Eli Lilly, alleging its Zepbound ads misleadingly compare doses against outdated Wegovy data.
Novo Nordisk has sued Eli Lilly in a U.S. court. The Danish company accuses Lilly of false advertising for its weight-loss…
Novo alleges Lilly compared the highest approved doses of its medicines with lower doses of Novo’s Wegovy and Ozempic while…
"Through this action, Novo Nordisk is seeking a permanent injunction requiring Lilly to pull its misleading comparative…
